Global Methylprednisolone Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Methylprednisolone Injection market size was valued at US$ 344 million in 2024 and is forecast to a readjusted size of USD 451 million by 2031 with a CAGR of 4.0% during review period.

Methylprednisolone is a synthetic corticosteroid medication used for its anti-inflammatory and immunosuppressive properties. It is commonly administered through intravenous injection and is indicated for various medical conditions such as allergic disorders, rheumatic disorders, skin diseases, respiratory diseases, and certain types of cancer.

The market for methylprednisolone injection is driven by factors such as the prevalence of inflammatory and autoimmune conditions, the need for effective anti-inflammatory medications, and the widespread use of corticosteroids in medical practice. Methylprednisolone injection is typically prescribed and administered by healthcare professionals in hospital settings, clinics, or other healthcare facilities.

The global methylprednisolone injection market is influenced by factors such as the availability of generic versions of the medication, regulatory policies, reimbursement frameworks, and the prevalence of conditions that require corticosteroid treatment. North America and Europe have traditionally been significant markets for methylprednisolone injection, given their well-established healthcare systems and a high burden of inflammatory and autoimmune diseases. The market in the Asia-Pacific region also shows potential for growth due to the increasing healthcare infrastructure and a rising prevalence of these conditions.

This report is a detailed and comprehensive analysis for global Methylprednisolone Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Methylprednisolone Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Methylprednisolone Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Methylprednisolone Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Methylprednisolone Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Methylprednisolone Injection

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Methylprednisolone Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sandoz, TEVA, Tianjin Kingyork, Nang Kuang Pharmaceutical Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd., Depo-Medrol, Sagent Pharms Inc, Amneal, Eugia Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Methylprednisolone Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
40mg
125mg

Market segment by Application
Hospital
Clinic
Others

Major players covered
Pfizer
Sandoz
TEVA
Tianjin Kingyork
Nang Kuang Pharmaceutical Co., Ltd.
Liaoning Haisco Pharmaceutical Co., Ltd.
Depo-Medrol
Sagent Pharms Inc
Amneal
Eugia Pharma
Par Sterile Products
Slayback Pharma Llc

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Methylprednisolone Injection product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Methylprednisolone Injection, with price, sales quantity, revenue, and global market share of Methylprednisolone Injection from 2020 to 2025.

Chapter 3, the Methylprednisolone Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Methylprednisolone Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Methylprednisolone Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Methylprednisolone Injection.

Chapter 14 and 15, to describe Methylprednisolone Injection sales channel, distributors, customers, research findings and conclusion.